| 2023/09/26 08:08:22 | |
|---|---|
| Price | |
| 150.70 EUR | |
| Difference | 0.00% (0.00) |
General attributes
| ISIN | US4781601046 |
| Symbol | JNJ |
| Exchange | Berlin |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 364,366 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 150.60 EUR (550) |
| Ask (Ask size) | 150.80 EUR (550) |
| Open | 150.70 EUR |
| High | 150.70 EUR |
| Low | 150.70 EUR |
| Close (prev. day) | 150.70 EUR |
| VWAP | 106.40 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: JOHNSON & JOHNSON |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2023/09/08 |
|
Global Equity Ratings |
|
| 2023/08/22 |
|
Global Equity Ratings |
|
| 2023/08/17 |
|
Global Equity Ratings |
|
| 2023/08/09 |
|
Global Equity Ratings |
|
| 2023/07/21 |
|
Global Equity Ratings |
|
| 2023/09/26 08:08:22 | |
|---|---|
| Price | |
| 150.70 EUR | |
| Difference | 0.00% (0.00) |
General attributes
| ISIN | US4781601046 |
| Symbol | JNJ |
| Exchange | Berlin |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 364,366 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 150.60 EUR (550) |
| Ask (Ask size) | 150.80 EUR (550) |
| Open | 150.70 EUR |
| High | 150.70 EUR |
| Low | 150.70 EUR |
| Close (prev. day) | 150.70 EUR |
| VWAP | 106.40 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +7.80% | -10.78% | +21.38% |
| Perf (abs.) | +10.90 | -18.20 | +26.54 |
| Beta | 0.09 | 0.32 | 0.34 |
| Volatility | 20.28 | 18.98 | 19.16 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 151.78 EUR (0) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 152.32 EUR (10) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 150.03 EUR (15) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 154.91 EUR (15) |
| YTD High | date | 170.40 EUR (2023/01/06) |
| YTD Low | date | 138.58 EUR (2023/03/23) |
| 52 Weeks High | date | 176.46 EUR (2022/10/31) |
| 52 Weeks Low | date | 138.58 EUR (2023/03/23) |
All listings for JOHNSON & JOHNSON
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| BX Swiss | 2023/09/21 | 18:00 | 146.392 CHF | 0.00 | 1 |
| Berlin | 2023/09/26 | 08:08 | 150.70 EUR | 0.00 | 1 |
| Duesseldorf | 2023/09/26 | 16:30 | 150.70 EUR | 0.00 | 4 |
| Frankfurt | 2023/09/26 | 16:19 | 150.80 EUR | 0.04 | 6 |
| Hamburg | 2023/09/26 | 09:52 | 151.40 EUR | 0.00 | 2 |
| Hanover | 2023/09/26 | 08:10 | 150.90 EUR | 0.00 | 1 |
| London Stock Exchange | 2023/09/26 | 16:51 | 159.34 USD | 0.11 | 18 |
| Munich | 2023/09/26 | 15:50 | 150.70 EUR | 0.02 | 2 |
| NYSE | 2023/09/26 | 17:02 | 159.57 USD | 179.15 | 26,468 |
| SIX Swiss Exchange | 2023/03/01 | 17:36 | 500.00 CHF | 0.00 | 1 |
| SIX Swiss Exchange | 2023/05/25 | 17:36 | 136.00 USD | 0.00 | 1 |
| Stuttgart | 2023/09/26 | 13:53 | 151.10 EUR | 0.01 | 3 |
| Tradegate | 2023/09/26 | 16:56 | 150.70 EUR | 0.43 | 74 |
| Vienna Stock Exchange | 2023/09/26 | 09:05 | 151.10 EUR | 0.00 | 1 |
| Xetra | 2023/09/26 | 16:30 | 150.70 EUR | 0.07 | 43 |
Company Logo
Contact Details
| JOHNSON & JOHNSON |
| - - |
| One Johnson & Johnson Plaza - 08933 New Brunswick |
| Telefon: +1-732-524-0400 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: JOHNSON & JOHNSON | |
Company Profile
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Womenšs Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. |
Members of Management Board
| A. Washington | Member of Board of Directors |
| Jennifer Doudna | Member of Board of Directors |
| Mark McClellan | Member of Board of Directors |
| Mary Beckerle | Member of Board of Directors |
| Nadja West | Member of Board of Directors |
| Paula Johnson | Member of Board of Directors |
| Anne Mulcahy | Member of Board of Directors |
| D. Davis | Member of Board of Directors |
| Darius Adamczyk | Member of Board of Directors |
| Hubert Joly | Member of Board of Directors |
| Marillyn Hewson | Member of Board of Directors |
| Mark Weinberger | Member of Board of Directors |
| Joaquin Duato | Chairman of Managing Board |
| Mathai Mammen | Member of Executive Committee |
| Peter M. Fasolo | Member of Executive Committee |
| William N. Hait | Member of Executive Committee |
| Ashley McEvoy | Member of Executive Committee |
| James Swanson | Member of Executive Committee |
| Jennifer Taubert | Member of Executive Committee |
| Joseph Wolk | Member of Executive Committee |
| Kathryn E. Wengel | Member of Executive Committee |
| Michael H. Ullmann | Member of Executive Committee |
| Thibaut Mongon | Member of Executive Committee |
| Vanessa Broadhurst | Member of Executive Committee |